 Aptose Biosciences Inc. NASDAQ:APTO Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Dr. William G. Rice Chairman, President and Chief Executive Officer Dr. Rafael Bejar Senior Vice President and Chief Medical Officer Dan Ferry Managing Director, LifeSci Advisors LLC Conference Call Participants Gregory Renza RBC Capital Markets Matthew Biegler Oppenheimer Co. Inc. Li Watsek Cantor Fitzgerald Matthew Cross Allegiance Global Partners Operator Welcome to the Aptose Biosciences o Incorporated Reports Result for the First Quarter 2022 Conference Call. 